Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: Implications for expanded use of myocardial perfusion imaging

Jeroen J. Bax*, Robert O. Bonow, Diethelm Tschöepe, Silvio E. Inzucchi, Eugene J. Barrett, Cliff J. Bailey, Carlos A. Buchpiguel, Terrence Chua, Alberto Cuocolo, Michael R. Freeman, Avijit Lahiri, Mario Ornelas Arrieta, Paul Poirier, Gerard Slama

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Patients with type 2 diabetes are at a markedly increased risk of a myocardial infarction than their non-diabetic peers. These patients often do not develop the classic warning signs of myocardial ischaemia, such as chest pain. Rather, they can display atypical symptoms or present with an acute myocardial infarction as the first indication of the presence of coronary artery disease. Current risk factor management techniques, largely based on risk factor scoring, have failed to identify this clinically important sub-population of patients, and the early diagnosis of silent myocardial ischaemia in this population would greatly aid risk stratification and subsequent therapy. Myocardial perfusion scintigraphy (MPS), using single-photon emission computed tomography (SPECT), has emerged as a specific and sensitive technique for detection of coronary artery disease in type 2 diabetic patients who have yet to develop signs or symptoms of coronary artery disease. Such abnormalities are common in this population, and are significantly associated with an increased risk of myocardial infarction or death from ischaemic heart disease. The current evidence supports MPS with SPECT as the methodology of choice for identifying silent myocardial ischaemia possibly improving cardiovascular risk stratification. Appropriate use of this technique allows earlier identification of coronary artery disease in diabetic patients.

Original languageEnglish
Pages (from-to)283-288
Number of pages6
JournalBritish Journal of Diabetes and Vascular Disease
Volume5
Issue number5
DOIs
Publication statusPublished - 1 Sep 2005

Fingerprint

Myocardial Perfusion Imaging
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Perfusion Imaging
Myocardial Infarction
Single-Photon Emission-Computed Tomography
Population
Risk Management
Chest Pain
Type 2 Diabetes Mellitus
Signs and Symptoms
Early Diagnosis

Keywords

  • Cardiovascular risk stratification
  • Coronary artery disease
  • Diabetes
  • Myocardial perfusion scintigraphy
  • Silent myocardial ischaemia
  • SPECT

Cite this

Bax, Jeroen J. ; Bonow, Robert O. ; Tschöepe, Diethelm ; Inzucchi, Silvio E. ; Barrett, Eugene J. ; Bailey, Cliff J. ; Buchpiguel, Carlos A. ; Chua, Terrence ; Cuocolo, Alberto ; Freeman, Michael R. ; Lahiri, Avijit ; Arrieta, Mario Ornelas ; Poirier, Paul ; Slama, Gerard. / Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease : Implications for expanded use of myocardial perfusion imaging. In: British Journal of Diabetes and Vascular Disease. 2005 ; Vol. 5, No. 5. pp. 283-288.
@article{651eb162829944c8b3df8d14f68b621e,
title = "Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: Implications for expanded use of myocardial perfusion imaging",
abstract = "Patients with type 2 diabetes are at a markedly increased risk of a myocardial infarction than their non-diabetic peers. These patients often do not develop the classic warning signs of myocardial ischaemia, such as chest pain. Rather, they can display atypical symptoms or present with an acute myocardial infarction as the first indication of the presence of coronary artery disease. Current risk factor management techniques, largely based on risk factor scoring, have failed to identify this clinically important sub-population of patients, and the early diagnosis of silent myocardial ischaemia in this population would greatly aid risk stratification and subsequent therapy. Myocardial perfusion scintigraphy (MPS), using single-photon emission computed tomography (SPECT), has emerged as a specific and sensitive technique for detection of coronary artery disease in type 2 diabetic patients who have yet to develop signs or symptoms of coronary artery disease. Such abnormalities are common in this population, and are significantly associated with an increased risk of myocardial infarction or death from ischaemic heart disease. The current evidence supports MPS with SPECT as the methodology of choice for identifying silent myocardial ischaemia possibly improving cardiovascular risk stratification. Appropriate use of this technique allows earlier identification of coronary artery disease in diabetic patients.",
keywords = "Cardiovascular risk stratification, Coronary artery disease, Diabetes, Myocardial perfusion scintigraphy, Silent myocardial ischaemia, SPECT",
author = "Bax, {Jeroen J.} and Bonow, {Robert O.} and Diethelm Tsch{\"o}epe and Inzucchi, {Silvio E.} and Barrett, {Eugene J.} and Bailey, {Cliff J.} and Buchpiguel, {Carlos A.} and Terrence Chua and Alberto Cuocolo and Freeman, {Michael R.} and Avijit Lahiri and Arrieta, {Mario Ornelas} and Paul Poirier and Gerard Slama",
year = "2005",
month = "9",
day = "1",
doi = "10.1177/14746514050050050801",
language = "English",
volume = "5",
pages = "283--288",
journal = "British Journal of Diabetes and Vascular Disease",
issn = "1474-6514",
publisher = "SAGE",
number = "5",

}

Bax, JJ, Bonow, RO, Tschöepe, D, Inzucchi, SE, Barrett, EJ, Bailey, CJ, Buchpiguel, CA, Chua, T, Cuocolo, A, Freeman, MR, Lahiri, A, Arrieta, MO, Poirier, P & Slama, G 2005, 'Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease: Implications for expanded use of myocardial perfusion imaging', British Journal of Diabetes and Vascular Disease, vol. 5, no. 5, pp. 283-288. https://doi.org/10.1177/14746514050050050801

Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease : Implications for expanded use of myocardial perfusion imaging. / Bax, Jeroen J.; Bonow, Robert O.; Tschöepe, Diethelm; Inzucchi, Silvio E.; Barrett, Eugene J.; Bailey, Cliff J.; Buchpiguel, Carlos A.; Chua, Terrence; Cuocolo, Alberto; Freeman, Michael R.; Lahiri, Avijit; Arrieta, Mario Ornelas; Poirier, Paul; Slama, Gerard.

In: British Journal of Diabetes and Vascular Disease, Vol. 5, No. 5, 01.09.2005, p. 283-288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Early detection of coronary heart disease in diabetic patients without symptoms of coronary artery disease

T2 - Implications for expanded use of myocardial perfusion imaging

AU - Bax, Jeroen J.

AU - Bonow, Robert O.

AU - Tschöepe, Diethelm

AU - Inzucchi, Silvio E.

AU - Barrett, Eugene J.

AU - Bailey, Cliff J.

AU - Buchpiguel, Carlos A.

AU - Chua, Terrence

AU - Cuocolo, Alberto

AU - Freeman, Michael R.

AU - Lahiri, Avijit

AU - Arrieta, Mario Ornelas

AU - Poirier, Paul

AU - Slama, Gerard

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Patients with type 2 diabetes are at a markedly increased risk of a myocardial infarction than their non-diabetic peers. These patients often do not develop the classic warning signs of myocardial ischaemia, such as chest pain. Rather, they can display atypical symptoms or present with an acute myocardial infarction as the first indication of the presence of coronary artery disease. Current risk factor management techniques, largely based on risk factor scoring, have failed to identify this clinically important sub-population of patients, and the early diagnosis of silent myocardial ischaemia in this population would greatly aid risk stratification and subsequent therapy. Myocardial perfusion scintigraphy (MPS), using single-photon emission computed tomography (SPECT), has emerged as a specific and sensitive technique for detection of coronary artery disease in type 2 diabetic patients who have yet to develop signs or symptoms of coronary artery disease. Such abnormalities are common in this population, and are significantly associated with an increased risk of myocardial infarction or death from ischaemic heart disease. The current evidence supports MPS with SPECT as the methodology of choice for identifying silent myocardial ischaemia possibly improving cardiovascular risk stratification. Appropriate use of this technique allows earlier identification of coronary artery disease in diabetic patients.

AB - Patients with type 2 diabetes are at a markedly increased risk of a myocardial infarction than their non-diabetic peers. These patients often do not develop the classic warning signs of myocardial ischaemia, such as chest pain. Rather, they can display atypical symptoms or present with an acute myocardial infarction as the first indication of the presence of coronary artery disease. Current risk factor management techniques, largely based on risk factor scoring, have failed to identify this clinically important sub-population of patients, and the early diagnosis of silent myocardial ischaemia in this population would greatly aid risk stratification and subsequent therapy. Myocardial perfusion scintigraphy (MPS), using single-photon emission computed tomography (SPECT), has emerged as a specific and sensitive technique for detection of coronary artery disease in type 2 diabetic patients who have yet to develop signs or symptoms of coronary artery disease. Such abnormalities are common in this population, and are significantly associated with an increased risk of myocardial infarction or death from ischaemic heart disease. The current evidence supports MPS with SPECT as the methodology of choice for identifying silent myocardial ischaemia possibly improving cardiovascular risk stratification. Appropriate use of this technique allows earlier identification of coronary artery disease in diabetic patients.

KW - Cardiovascular risk stratification

KW - Coronary artery disease

KW - Diabetes

KW - Myocardial perfusion scintigraphy

KW - Silent myocardial ischaemia

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=28444472099&partnerID=8YFLogxK

UR - https://journals.sagepub.com/doi/10.1177/14746514050050050801

U2 - 10.1177/14746514050050050801

DO - 10.1177/14746514050050050801

M3 - Article

AN - SCOPUS:28444472099

VL - 5

SP - 283

EP - 288

JO - British Journal of Diabetes and Vascular Disease

JF - British Journal of Diabetes and Vascular Disease

SN - 1474-6514

IS - 5

ER -